IL6 and inflammatory bowel disease: Genome wide association studies have identified single nucleotide polymorphisms (SNPs) in the genome associated with many autoimmune conditions, including IBD, and have identified certain cytokines and receptor targets for treatment development via the JAK/STAT signaling pathway including IL-1, IL-6, IL-12, IL-23 and STAT3 [53].